[1]CurrentPatentAssignee:MERCK&COINC-WO2013/66734,2013,A1Locationinpatent:Page/Pagecolumn29-30
[1]CurrentPatentAssignee:MERCK&COINC-WO2013/66734,2013,A1
10233-13-3
1139-13-5
117-47-5
123-29-5
123-66-0
124-06-1
885274-22-6 | 2-Amino-6-fluoro-1,2,3,4-tetrahydro-naphthalene-2-carboxylic acid | AA0046ZA | MFCD04114923
88919-22-6 | 3-(2-Aminoethyl)-n-methyl-1h-indole-5-methanesulfonamide | AA00485W | MFCD08063851
88495-55-0 | (S)-Piperidine-3-carboxylic acid amide | AA0049E3 | MFCD17015911
886365-22-6 | 5-Bromo-2-methoxy-isonicotinic acid | AA004AC5 | MFCD07375111
88260-11-1 | N-(2-Aminoethyl)-5-methylpyridin-2-amine | AA004BXR | MFCD09936826
88-45-9 | 2,5-Diaminobenzenesulfonic acid | AA004DI6 | MFCD00007904
88070-98-8 | HELSS (Haloenol lactone suicide substrate, BEL, Bromoenol lactone) | AA004ERA | MFCD00270871
881040-70-6 | Hexahydro-2-[(3-methyl-4-pyridinyl)methyl]-1h-azepine | AA004G0F | MFCD06653408
876716-29-9 | 2-Phenyl-2-(1H-tetrazol-1-yl)acetic acid | AA004H3F | MFCD07186413
868755-53-7 | 6-(Morpholin-4-yl)pyridine-2-carbonitrile | AA004I9G | MFCD08690244